Several pharmaceutical groups are trying to muscle in on a potentially lucrative market

Issue Contents

Case study
Editor's View
Feature
Great Ideas
Investment Trusts
News
Personal Finance
Russ Mould
Under The Bonnet
Week Ahead

Issue Contents

Case study
Editor's View
Feature
Great Ideas
Investment Trusts
News
Personal Finance
Russ Mould
Under The Bonnet
Week Ahead